Evidence map›Paper›PMID 31314593›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

Sylwia Bartoszewska, Aleksandra Cabaj, Michał Dąbrowski, James F Collawn, Rafal Bartoszewski

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Old drugs, new challenges: reassigning drugs for cancer therapies.Cellular & molecular biology letters · 2025
    Review
  5. Article
  6. Article
  7. MiR-34c-5p Inhibition Affects Bax/Bcl2 Expression and Reverses Bortezomib Resistance in Multiple Myeloma Cells.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2024
    Article
  8. Review
  9. Review
  10. Article
  11. Dual RNase activity of IRE1 as a target for anticancer therapies.Journal of cell communication and signaling · 2023
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. The hypoxia-induced changes in miRNA-mRNA in RNA-induced silencing complexes and HIF-2 induced miRNAs in human endothelial cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Sylwia BartoszewskaDepartment of Inorganic Chemistry, Medical University of Gdansk, Gdansk, Poland.
Aleksandra CabajLaboratory of Bioinformatics, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
Michał DąbrowskiLaboratory of Bioinformatics, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
James F CollawnDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Rafal BartoszewskiDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Gdansk, Poland.
Gdańsk Medical University · PLInstytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLPolish Academy of Sciences · PLUniversity of Alabama at Birmingham · US

Funding

UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI David M. Bedwell · 2007 to 2026
$23.0M
NIDDK NIH HHS P30 DK072482
6 · The paper itself

Abstract

During endoplasmic reticulum (ER) stress conditions, an adaptive signaling network termed the unfolded protein response (UPR) is activated. The UPR's function is to increase ER protein-folding capacity in order to attenuate ER stress, restore ER homeostasis, and, most importantly, promote cell survival. X-box-binding protein 1 (XBP1) is one component of the UPR and is a proadaptive transcription factor that is subject to transcriptional, post-transcriptional, and post-translational control. In the present study, we identified a post-transcriptional mechanism mediated by

Indexed as

ApoptosisCell Line, TumorEndoplasmic ReticulumEndoplasmic Reticulum StressGene Expression RegulationHeLa CellsHumansMicroRNAsProtein FoldingRNA, MessengerRNA Processing, Post-TranscriptionalRNA SplicingSignal TransductionTranscription, GeneticUnfolded Protein ResponseX-Box Binding Protein 1MicroRNAsMIRN34 microRNA, humanRNA, MessengerX-Box Binding Protein 1XBP1 protein, humanER stressmiRNAUPRXBP1

Identifiers

PMID31314593
PMCPMC6766644
OpenAlexW2961368723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.